Vicore Pharma starts Phase I trial of angiotensin II type 2 receptor agonist | #type 2 angiotensin ii receptor Drugs Development Market
Vicore Pharma starts Phase I trial of angiotensin II type 2 receptor agonist | #type 2 angiotensin ii receptor Drugs Development Market
Seres and Nestlé enter up to $525m deal for microbiome therapeutic | #clostridioides difficile infections Drugs Development Market
Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia | #chronic liver disease drugs development Market
Juventas begins patient enrolment in Phase II gene therapy trial for peripheral artery disease | #wound Closure Devices market
Colorectal cancer incidence in urban China will overtake the US in the next 10 years | #colorectal Cancer Market